Introduction {#sec1-1}
============

Vital evidence is needed to understand the effect of dietary phytoestrogens and related compounds on human growth regulation and their impact on health and disease. This review brings together strands of evidence which support the view of moderating our diet, and offers potential solutions to the global epidemic of cardiovascular disease and endocrine cancer through selective dietary practice and functional foods. The first of the four sections sets the epigenetic scene and the dietary context. The second section identifies some basic structures that are candidate phytoestrogens likely to influence enzyme systems and influence mechanisms of hormone action in endocrine cancer; and action as antioxidants. The third section describes possible human phytoestrogen interaction with the epigenome before and after transplantation of the fertilized egg (germ layers before differentiation: brain, liver and kidney); the foetal development of maleness; the prenatal endocrinology; and that of puberty and adulthood. Finally, the fourth section provides dietary intervention concepts that provide insight into dietary advice and the development of functional foods against a backdrop of global epidemiological and notional Palæolithic dietary evidence supported by a beneficial lifestyle.

Epigenetics {#sec1-2}
===========

Gregor Mendel\'s experiments[@ref1] from 1853-1863 on *Pisum sativum* at the Augustinian Abbey of St Thomas in Brno, Czech Republic led to two generalizations known as the Law of Segregation and the Law of Independent Assortment, which were then collectively known as Mendel\'s Laws of Inheritance. It was McClintock\'s techniques[@ref2] that allowed her to confirm experimentally the work of Thomas Hunt Morgan[@ref3] on crossover *viz*. that genetic traits were associated with an exchange of genetic material by chromosomes *i.e*. parts of the genome can jump around and cause mutations or alter gene expression. McClintock[@ref4] recognized that the epigenetics was taking place even before the structure of DNA was elucidated[@ref5]. Over the next 50 years or so theories were developed *i.a*. on diet or the wider environment and how such factors might bring about beneficial change[@ref6][@ref7][@ref8]. When Bird defined epigenetics as 'the structural adaption of chromosomal regions to register, signal or perpetuate altered activity states'[@ref9], the strait-jacket of heritability was loosened, because this description focussed on genes and chromosomes and epigenetic marks, that once deposited, adapted to environmental and intrinsic stimuli.

Critical timings for epigenetic change and expression {#sec1-3}
=====================================================

Flavonoids, food restriction, and omega-3 fatty acids may exert epigenetic changes[@ref8] that produce phenotypes for disease such as cancer, cardiovascular, and many other diseases. The regulation of these marks and subsequent transcription may involve the now well-known DNA methylation, post-translational histone modifications[@ref10], and ncRNAs (non-coding RNAs)[@ref11]. The ability of a DNA sequence or transcript to regulate the expression of one or more genes on the same chromosome (cis) or different chromosomes, or mature RNAs in the cytoplasm (trans), is extremely important in the development of the placenta and foetus. These regulatory mechanisms serve to express imprinted (parent-of-origin specific) and non-imprinted genes which lead to placental development in such a way that might adversely affect the health of the foetus, and/or mother, in both short- and long-term. The process is more complex: the imprintor is a protein that exercises control over a region of the genome such that the imprint may give rise to changes in development later in life. Epigenetic marks that are imprints are predominantly in clusters within the genome and wish to preserve their parent-origin monoallelic expression[@ref12].

Flavonoid imprinting {#sec1-4}
====================

This paper focuses on the endocrinology of human development and the potential importance of imprinting in the aetiologies of breast and prostate cancer wherein dietary flavonoids and natural oestrogens may exert influence and potentially offer hope for the development of functional foods. It also draws attention to the notional Palæolithic diet with fruits, vegetables, roots, leaves, seeds, honey, meat, fish and eggs *i.a*. which have a low w-6/w-3 ratio of fatty acids, high monounsaturated fatty acids, fibre, phytochemical antioxidants and proteins. Phytoestrogens, *viz*. lignans, isoflavonoids and flavonoids are weak oestrogenic constituents of such a diet and may have a considerable impact on human health and disease at critical stages of human development[@ref13]. In the ancient Indian systems of Ayurvedic and Siddha medicine, healers treated patients with asthma and other breathing disorders with diet, exercise, and herbs. Although not obviously subscribing to the concept of an immortality drink, mythologically appearing in at least two Indo-European cultures, *viz*. Greek and Sanskrit, ambrosia and amrita, it is highly probable that much dietary information can be gleaned and applied to enhancing longevity with a good quality of life starting with the epigenetics of foeto-placental development, leading to pivotal expression in perinatal and pubertal stages that perhaps express or inhibit the onset of endocrine and cardiovascular related diseases ([Fig. 1](#F1){ref-type="fig"}).

![The interrelation between dietary xenoestrogens and phytochemicals in male and female that may introduce an exogenous gene (transgenesis), and evoking the widely accepted theory that an individual animal develops by the gradual differentiation and elaboration of a fertilized egg cell, as indicated, through DNA methylation and other changes, *e.g*. histone modifications (epigenetics) which imprint on foeto-placental development and lifetime risk of non-communicable diseases. SDN-POA refers to the sexual dimorphic nucleus located in the pre-optic area of the brain which is linked to sexual behaviour; AVPV is the anteroventral periventicular nucleus of the hypothalamus and is particularly implicated in imprinting rats. The chemical structures (lower right) refer to testosterone and oestradiol (maleness/femaleness). The term by the thousand implies a multifarious very large indeterminate number of compounds.](IJMR-140-82-g001){#F1}

Candidate phytoestrogen molecular prerequisites {#sec1-5}
===============================================

These candidates must at least, satisfy certain criteria if these are to be used for healthcare[@ref14]. These must be present in the human diet although this is not an absolute requirement. These must be present in biological fluids (*e.g.* urine, blood, saliva, prostatic fluid, breast aspirates). These must be absorbed/metabolized and the uptake substantial enough to elicit a timely demonstrable beneficial effect at cellular/tissue level. It is this latter statement which is critical to understanding risk of disease at different stages of human development; lifetime safety is difficult to measure. Overall, the benefits must outweigh any adverse effects so that these can become components of a functional food, synthesised or otherwise to reflect epidemiological concentrations of bioflavonoids in populations at lower risk of disease, or as a product *per se*.

Pathogenicity {#sec1-6}
=============

It is likely that based on chemical structure and receptor mechanisms, phytoestrogens exhibit antagonist or agonist interaction with natural oestradiol in endocrine tissues, principally, brain uterus, breast and prostate. For example, in the mouse uterine growth test for various phytoestrogens, it seems that the spatial spatial distance of 10.3 Å between the C3 and C18 atoms of the oestradiol molecule is a key feature of such oestrogenic activity because this spatial difference is also present between the C3 and C18 of miroestrol and the C7 and C4 configurations of genistein and other similar compounds showing similar activity[@ref15]. On this and a colossal amount of historical evidence on a mouse bioassay[@ref16] subsequently developed over time, with later development of cell lines, there is need to be cautious -- research on hormone replacement therapy and oral contraceptives testify to potential problems. However, flavonoid benefits, probably mainly through oestrogen-like activity and antioxidant mechanisms for scavenging free radicals[@ref17], seem to have an impact on cardiovascular disease (myocardium, microvasculature. smooth muscle cell. cerebrum); metabolic disorders (type II diabetes, metabolic syndrome, obesity; cancer (breast. prostate, ovary, endometrium, cervix, Erhlich ascites tumour); brain and mental health (Alzheimer\'s disease, Parkinson\'s disease, multiple sclerosis, cognition, neurodegeneration), gastrointestinal issues and related cancer (mouth, stomach, oesophagus, colon-rectum, liver, pancreas, gut microflora); and other benefits effected possibly at key times of human development as adjudged from mainly rodent experimentation[@ref18].

Identification of candidate molecular structures {#sec1-7}
================================================

The flavonoids investigated comprised[@ref15], *i.a*., flavones (leafy spices: apigenin), flavonols (widespread in many foods: kaempferol, quercetin), flavanone (citrus fruits: hesperetin, naringenin), flavanols (grapes/red wine: catechins, epicatechins, and gallocatechins and gallates), and isoflavonoids (*Leguminosae*: genistein, diadzein, biochanin A, formononetin). Theaflavins and thearubigins[@ref19] and other polyphenolic compounds are also found in beverages. Historically, 'oestrogen-like' activity has been reported by several groups[@ref20][@ref21][@ref22][@ref23][@ref24].

Phytoestrogens in foods: composition {#sec1-8}
====================================

Generally, these data are scattered among several thousand publications and largely pertain to rodents and humans under a variety of experiment conditions but progress on integrating information is being made in several countries, *e.g.* Finland. Finnish workers[@ref25] have extended the Finnish National Food Composition Database (Fineli) for lignans: 180 foods for lignans and 160 foods for isoflavones, *etc*. The mean lignan intake was 434 μg/day and the isoflavone intake was 788 μg/day. The sources of lignans included seeds, cereals, fruit, berries and vegetables and for isoflavones were processed meat products/sausages containing soya as an ingredient, and legumes. However, values for most compounds are highly dispersed and exhibit wide ranges between and within subjects for particular dietary scenarios and any experimental designs on dietary comparisons should take cognisance of this fact.

Pitfalls and limitations of using cell and tissue culture {#sec1-9}
=========================================================

The choice of animal or cell line model is of fundamental importance if extrapolation to the human is to be made: for example, the similarities and contrasts in the anatomy, physiology and biochemistry of the human compared to guinea pig, rat and canine species in trying to model benign prostatic hyperplasia (BPH). A cell culture is an artificial system in the sense that cultures developed on hard flat surfaces, colonies, are hardly representative of the tissue milieu in three-dimension but when cells are grown in suspensions, then any intercellular signalling activity or physical or biochemical influences occurring *in vivo* must be of concern. Often candidate molecules, under test in 'placebo/control' situations, represent simply a small part in a very complex system *in vivo* where physiology, anatomy, and biochemistry and body clocks operate throughout the body with attendant regulatory mechanisms[@ref14]. Dietary phytoestrogens studies must have a biochemical scientific audit trail from food, digestion, uptake into blood, tissue distribution, and excretion(s) and proper measurements and experimental design are needed to augment screening methods in culture.

Placental-foetal imprinting {#sec1-10}
===========================

It is now over 40 years since Herbst and Scully[@ref26] noticed an association of mothers treated with diethylstilboestrol for impending abortion during the first trimester and the occurrence of vaginal adenocarcinomas in their daughters. This occurrence was much earlier than usual and this observation was a landmark discovery of transplacental imprinting. The number of mothers taking stilboestrol in the 1960s on the increase[@ref26]. The foetal site of biological origin was believed to be in the Müllerian ducts which develop into the fallopian tube, uterus and cervix and the upper two thirds of the vagina. The US Department of Agriculture banned the use of stilboestrol in animal feed for seven days prior to slaughter[@ref27]. It would seem that other co-factors, other than toxicity, were operating in this transgenerational condition. It would be appropriate for those adolescent girls and women whose mothers were treated with stilboestrol to have vaginal examinations; those landmark cases with adenocarcinomas[@ref28] had a delayed diagnosis because vaginal bleeding was mistaken for anovulatory cycles. The molecular processes involved in gene imprinting are complex. Given the correlation of breast and prostate cancers, consideration of some common aetiology was sought, such as diet, having influence on the development of the Wolffian duct signalling risk of prostate cancer initiated and developed in future years. What is the trigger for such tumour development: is it related to mechanisms in adolescence or something more subtle? Perhaps brain-body interaction in the neonatal period of development, or epigenetic deregulation needs to be elucidated but discussion on embryonic mechanisms of Wolffian duct development[@ref29] is outside the scope of this paper.

Environment-driven changes in epigenetic regulation occurring in pre- and post- natal development suggest a link to predisposition to cardiovascular disease, diabetes, metabolic syndrome, obesity and mental conditions[@ref30]. A well-known example is the effect of maternal diet on coat colour and obesity in Avy/a mice offspring[@ref31]. Other environmental factors like tobacco smoke, alcohol, radiation and chemicals have been shown to influence disease susceptibility and can even induce transgenerational phenotypic effects such as drugs[@ref32] and nutrition[@ref33][@ref34]. One of the best known examples in humans is the effect of diethylstilbestrol, which was given to pregnant women in the sixties, to prevent miscarriages[@ref35]. This chemical, however, leads to uterus malformations in the offspring, caused by epigenetic deregulation[@ref35][@ref36][@ref37]. On the one hand, there are several types of oestrogen such as those used for birth control, hormone-replacement therapy and in feed supplements for livestock, *etc*. There are innumerable xenoestrogens in plastics, pesticides, herbicides, phthalates, and excretion products that find their way into watercourses, and although diluted may re-appear in recycled water. Nature produced salicylic acid from salicin \[an extract from the inner bark of white willow (*Salix alba*)\], which exists in plants for the biological defence of the plant but, subject to circadian timing and dose, also aids human well-being. There is now evidence to support the action of phytoestrogens in foetal development, particularly mice fed soy food after fertilization but before germ layer differentiation, where effects persist into adulthood, at least in the mouse[@ref38].

Maleness and femaleness {#sec1-11}
=======================

Effective transfer of phytoestrogens probably takes place from mother to foetus[@ref39] which may have some influence on the hierarchal mechanisms involved in the sexual differentiation in the brain. The early work of Jost *et al*[@ref40] demonstrated that male gonads were required for male phenotype with regression of Müllerian duct development by the anti-Müllerian hormone secreted from Sertoli cells. Foetal castration produced the female phenotype and unilateral castration produces an ipsilateral Müllerian duct. A similar type of unilateral action of the testis on the growth of the prostate was also discovered in experiments involving the epididymides, vas deferens and deferential vein[@ref41]. Many experiments were conducted[@ref12] which demonstrated that androgens were needed for maleness.

Phytoestrogens in perinatal period {#sec1-12}
==================================

In rats there is a critical perinatal period in which the androgen is responsible for programming higher centres of the brain and soy food given to rats decreases Leydig cell secretion of androsterone and testosterone[@ref42]. In rats, perinatal but not 'postnatal' isoflavone exposure gave improved bone mineral density[@ref43].

Phytoestrogens inhibit key enzymes (5α-reductase, 17β-hydroxysteroid dehydrogenase, tyrosine kinase) that are implicated in androgen/oestrogen metabolism and growth regulatory pathways, and in the latter context may inhibit angiogenesis. Sexually dimorphic nucleus of the preoptic area (SDN-POA) volumes in rats were significantly increased by phytoestrogens[@ref44], predominantly isoflavones, compared to control and in maze experiments produced a better performance in females and a poorer performance in males. It is possible that phytoestrogens may have an impact on the growth and protection of cholinergic neurones and it remains to be seen whether these are beneficial against neural damage such as Alzheimer\'s disease.

Intervention concepts-Phytoestrogens in adolescence and adulthood: lifetime risk of breast and prostate cancer {#sec1-13}
==============================================================================================================

**Female:** Putting endocrine disruptors aside, *e.g.* pharmacological, biocidal and herbicidal products, plastics, *etc*., dietary phytoestrogens probably have an impact on the endocrine status of the individual. In the female, the key stages of life are foeto-placental development (epigenetics), perinatal environment, *e.g.* milk consumption and hormonal environment, puberty/menarche and adolescence and lifestyle, pregnancy, menopause and post-menopause. Although the oestrogen effects on breast cancer risk are well known (lower risk: later age at menarche, earlier age at first pregnancy, early menopause, *etc*.), these do not adequately account for the geographical/ethnic differences which undoubtedly involve diet and lifestyle, particularly soy foods in Asiatic populations. For example, a comparison between British and Thai postmenarchal girls[@ref45] show that the British girls, who were generally larger and not so lean appear to develop their ovulatory cycles earlier; and leaner athletes have lower breast cancer risk. A vegetarian lifestyle of white American girls was also associated with a later age at menarche[@ref46]. Although not conclusive, phytoestrogens and a Palæolithic diet may be the reason, because the oestrogen-adsorptive faecal fibre may lead to a fall in plasma oestrogens and this has an impact on the hypothalamus and development of the luteinizing hormone-releasing hormone (LHRH) generator. It would seem that isoflavones do have other possible biological functions. An experiment by Mardon *et al*[@ref43] provides evidence that phytoestrogen exposure may lead to a higher bone mineral density (BMD) later in life. In an earlier study a positive correlation was found between prostatic cancer and female breast cancer incidence in 24 countries suggesting a common aetiology[@ref47] and dietary oestrogens have since been strongly implicated as a major factor[@ref13]. So the underlying thrust of this paperbuilds on the questions posed by Wynder *et al*[@ref47], *viz*. 'Is there commonality in breast and prostate cancer'and 'Could dietary phytoestrogens and related compounds have a role in ameliorating oestrogenic effects to reduce cancer? [Fig. 2](#F2){ref-type="fig"} shows windows of risk/exposure for the prostate and it may well be that, in principle, the model for female oestrogen risk for breast caner is not too dissimilar.

![Hypothetical model of stages in the development of benign prostatic hyperplasia (BPH) and cancer. The influence of phytoestrogens on sexual dimorphism, and later in life, the increasing oestrogen status in the male may be redressed by phytoestrogens at mid-life and hence reduces the incidence of clinical BPH and cancer. Prostatic intraepithelial neoplasia (PIN), a possible premalignant lesion may lead to cancer unless restrained by phytoestrogens. E2/T ↑ refers to the relative rise in oestradiol/testosterone ratio of the ageing male.](IJMR-140-82-g002){#F2}

**Male:** [Fig. 2](#F2){ref-type="fig"} shows a schema for the possible development of malignant and benign prostatic tumours. The importance of *in utero* and perinatal timing has been discussed, *vide supra*, and it is the period around puberty and early sexual activity that an imbalance in growth regulation might occur[@ref48]. Contrary to perhaps uninformed expectation, oestrogen imbalance over androgens has been inferred/stated in relation to the development of benign enlargement of the prostate[@ref48][@ref49][@ref50]. As (BPH) and cancer occur in the older man, it is possible that it is the increasing oestrogen status in the male which influences the regulatory growth of the prostate. This suggests that androgen replacement therapy or phytoestrogens, acting through receptor or signalling mechanisms, can redress the androgen/oestrogen imbalance at mid-life and reduce the incidence of clinical BPH and cancer.

**Gastrointestinal disease:** Gastrointestinal activities play a crucial role in phytoestrogen metabolism. Black tea has a prokinetic effect which may have some importance in health: also some dietary phytoestrogens are believed to have antioxidant, antiviral, anti-inflammatory, antibacterial, and anticarcinogenic properties. One encouraging role for green tea polyphenols and some spices in inflammatory diseases such as atherosclerosis, myocardial infarction, diabetes, arthritis, Crohn\'s disease, *etc*. is the interruption/modulation of the activation of nuclear transcription factor-kappaB[@ref51]. There is growing evidence to suggest "reasoning for seasoning". Though it has to be said not all responses are related to phytoestrogens but certainly more research is needed in this promising field.

In conclusion, epidemiological evidence suggests that differences in diet are responsible for much of the global differences in non communicable diseases (NCDs) observed; and phytoestrogens appear to have some commonality with the Palæolithic or Mediterranean diet. The literature abounds with inference about the potential benefits of phytoestrogen from the work of Doll and Peto[@ref52] some years ago which suggested 35 per cent of cancer deaths, range 10-70 per cent, could be attributed to diet. The celebrated Japanese epidemiologist, Takeshi Hirayama[@ref53], provided evidence that intake of green-yellow vegetable (GYV) soup, often with soybean soup, presumably rich in phytoestrogens, was associated with a reduction in mortality from breast and prostate cancer. Later studies by Adlercreutz (and his group)[@ref54], demonstrated, *i.a*., that daidzein and genistein were higher in Japanese and Chinese, who are large consumers of soy products. It is pertinent to point out that a number of epidemiological studies have not demonstrated an association between prostatic cancer risk and phytoestrogens[@ref55], but given the multifarious aspects of such dietary investigation it is of crucial importance to have good experiment design such as the 'setting', the sampling framework, the instruments used, the analytical techniques, national food-phytoestrogen databases, and contributions from endocrinologists, nutritionists, and those from the food production and manufacturing industry of which tea production is a good example. New phytochemicals are being found almost every day from wild Yichun blue honeysuckle (*Lonicera caerulea* L.) berries containing high level of anthocyanins which has strong antioxidant activity to quercetin inhibition of alpha-glucosidases of importance in glucose control in type 2 diabetes[@ref56]. It is possible, given proper research evaluations and outcomes, that safe functional food products could be manufactured based on epidemiological information.
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